1. Home
  2. ANEB vs GRCE Comparison

ANEB vs GRCE Comparison

Compare ANEB & GRCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANEB
  • GRCE
  • Stock Information
  • Founded
  • ANEB 2020
  • GRCE 2002
  • Country
  • ANEB United States
  • GRCE United States
  • Employees
  • ANEB N/A
  • GRCE N/A
  • Industry
  • ANEB Biotechnology: Pharmaceutical Preparations
  • GRCE
  • Sector
  • ANEB Health Care
  • GRCE
  • Exchange
  • ANEB Nasdaq
  • GRCE NYSE
  • Market Cap
  • ANEB 36.7M
  • GRCE 35.6M
  • IPO Year
  • ANEB 2021
  • GRCE N/A
  • Fundamental
  • Price
  • ANEB $1.33
  • GRCE $3.45
  • Analyst Decision
  • ANEB Buy
  • GRCE
  • Analyst Count
  • ANEB 1
  • GRCE 0
  • Target Price
  • ANEB $8.00
  • GRCE N/A
  • AVG Volume (30 Days)
  • ANEB 12.4K
  • GRCE 132.1K
  • Earning Date
  • ANEB 02-14-2025
  • GRCE 02-13-2025
  • Dividend Yield
  • ANEB N/A
  • GRCE N/A
  • EPS Growth
  • ANEB N/A
  • GRCE N/A
  • EPS
  • ANEB N/A
  • GRCE N/A
  • Revenue
  • ANEB N/A
  • GRCE N/A
  • Revenue This Year
  • ANEB N/A
  • GRCE N/A
  • Revenue Next Year
  • ANEB N/A
  • GRCE N/A
  • P/E Ratio
  • ANEB N/A
  • GRCE N/A
  • Revenue Growth
  • ANEB N/A
  • GRCE N/A
  • 52 Week Low
  • ANEB $0.80
  • GRCE $2.13
  • 52 Week High
  • ANEB $3.30
  • GRCE $4.97
  • Technical
  • Relative Strength Index (RSI)
  • ANEB 36.62
  • GRCE N/A
  • Support Level
  • ANEB $1.45
  • GRCE N/A
  • Resistance Level
  • ANEB $1.61
  • GRCE N/A
  • Average True Range (ATR)
  • ANEB 0.12
  • GRCE 0.00
  • MACD
  • ANEB -0.03
  • GRCE 0.00
  • Stochastic Oscillator
  • ANEB 0.00
  • GRCE 0.00

About ANEB Anebulo Pharmaceuticals Inc.

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.

About GRCE GRACE THERAPEUTICS INC

Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.

Share on Social Networks: